Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A)

Gregory W. Thomas; Leonard T. Rael; Charles W. Mains; Denetta Slone; Matthew M. Carrick; Raphael Bar-Or; David Bar-Or

doi:10.1080/15321819.2015.1047516

Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A)

Gregory W. Thomas
, Leonard T. Rael
, Charles W. Mains
, Denetta Slone
, Matthew M. Carrick
, Raphael Bar-Or
, David Bar-Or

a Swedish Medical Center , Trauma Research Department , Englewood , Colorado , USA.
Swedish Medical Center, Trauma Research Department, Englewood, Colorado, USA; St. Anthony Hospital, Lakewood, Colorado, USA; The Medical Center of Plano, Plano, Texas, USA
b St. Anthony Hospital , Lakewood , Colorado , USA.
Rocky Vista University College of Osteopathic Medicine
c The Medical Center of Plano , Plano , Texas , USA.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Immunoassay & Immunochemistry
Volume	37
Issue number	1
DOIs	https://doi.org/10.1080/15321819.2015.1047516
State	Published - Jan 12 2016
Externally published	Yes

Disciplines

Immunology and Infectious Disease
Pharmacology
Medicine and Health Sciences

Access to Document

10.1080/15321819.2015.1047516License: Unspecified

Cite this

@article{9c2f23b3e4f542b8be00d048a4adb90a,

title = "Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A)",

author = "Thomas, \{Gregory W.\} and Rael, \{Leonard T.\} and Mains, \{Charles W.\} and Denetta Slone and Carrick, \{Matthew M.\} and Raphael Bar-Or and David Bar-Or",

note = "The innate immune system is increasingly being recognized as a critical component in osteoarthritis (OA) pathophysiology. An ex vivo immunoassay utilizing human peripheral blood mononuclear cells (PBMC) was developed in order to assess the OA anti-inflammatory properties of the low molecular weight fraction (<5 kDa) of commercial human serum albumin (LMWF5A).",

year = "2016",

month = jan,

day = "12",

doi = "10.1080/15321819.2015.1047516",

language = "American English",

volume = "37",

journal = "Journal of Immunoassay \& Immunochemistry",

number = "1",

}

TY - JOUR

T1 - Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A)

AU - Thomas, Gregory W.

AU - Rael, Leonard T.

AU - Mains, Charles W.

AU - Slone, Denetta

AU - Carrick, Matthew M.

AU - Bar-Or, Raphael

AU - Bar-Or, David

N1 - The innate immune system is increasingly being recognized as a critical component in osteoarthritis (OA) pathophysiology. An ex vivo immunoassay utilizing human peripheral blood mononuclear cells (PBMC) was developed in order to assess the OA anti-inflammatory properties of the low molecular weight fraction (<5 kDa) of commercial human serum albumin (LMWF5A).

PY - 2016/1/12

Y1 - 2016/1/12

UR - https://europepmc.org/article/MED/25961642

U2 - 10.1080/15321819.2015.1047516

DO - 10.1080/15321819.2015.1047516

M3 - Article

VL - 37

JO - Journal of Immunoassay & Immunochemistry

JF - Journal of Immunoassay & Immunochemistry

IS - 1

ER -

Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A)

Disciplines

Access to Document

Other files and links

Cite this